目的 建立液相色谱-串联质谱 (LC-MS/MS)测定兔血浆中B07的浓度。方法 血浆样品经碱化沉淀蛋白后,用甲基叔丁基醚液-液萃取,以乙腈(含0.2%乙酸)-40 mmol·L-1乙酸铵(含0.2%乙酸)水溶液 (80∶20) 为流动相,采用Waters Symmetry C18 (4.6 mm×150 mm,5 μm)柱分离;采用电喷雾电离源,以多反应监测(MRM)方式进行正离子检测,用于定量分析的离子对B07为529.3→335.4,内标卡马西平为237.1→194.1。结果 测定血浆中B07线性范围为0.31~310 ng·mL-1,r>0.99。日内和日间精密度小于15%,提取回收率均大于75%。结论 该法选择性强、灵敏度高、重现性好,能够快速、准确测定兔血浆中B07浓度。
Abstract
OBJECTIVE To devolop a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the determination of B07 in rabbit plasma.METHODS Analytes were separated from plasma by a combination of alkalinized protein precipitation and liquid-liquid extraction with methyl tert-butyl ether. Chromatographic separation was performed on a Waters Symmetry C18 (4.6 mm×150 mm, 5 μm)column with the mobile phase consisted of acetonitrile (containing 0.2% acetic acid ) -40 mmol·L-1 ammonium acetate (containing 0.2% acetic acid) in water (80∶20). A tandem mass spectrometer equipped with electrospray ionization source was used as detector and operated in the positive ion mode. Quantification was performed using multiple reaction monitoring (MRM) of the transitions m/z 529.3→335.4 and m/z 237.1→194.1 for B07 and carbamazepine (internal standard), respectively.RESULTS The method showed a good linearity in a concentration range of 0.31-310 ng·mL-1for B07 was more than 0.99. The intra- and inter-day precision was less than 15% and the absolute recovery was above 75%.CONCLUSION This method was selective and rapid, sensitive for investigating blood drug concentrations in rabbit.
关键词
B07 /
液相色谱-串联质谱法 /
液-液萃取 /
血药浓度
{{custom_keyword}} /
Key words
B07 /
LC-MS/MS /
liquid-liquid extraction /
plasma concentration
{{custom_keyword}} /
中图分类号:
R969.1
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1]DONG M, LU L, LI H, et al. Design,synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors[J]. Bioorg Med Chem Letters, 2012,22(9):3284-3286. [2]YE J H, ZHOU S M, WANG Q, et al. Design, synthesis and activity evaluation of new anti-HIV-1 CXCR4 inhibitors[J]. Mil Med Sci(军事医学), 2014,38(8):602-607. [3]MAO W X, DONG M X, ZHU W G, et al. Design, synthesis and biological activity of bicyclic piperidine-based HIV-1 inhibitors [J]. Chin J Med Chem(中国药物化学杂志), 2011,21(3):169-177.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家十二五重大新药创制抗艾滋病病毒新药临床评价研究技术平台建设项目资助(2012ZX09303013);国家自然科学基金项目资助(81271834);国家863课题“病原微生物实验室溯源和人员防护关键技术的研究”项目资助(2014AA021403);上海市高等级生物安全病原微生物检测专业技术服务平台项目资助(15DZ2290200)
{{custom_fund}}